Delivery Order SPE2DB22D2206-SPE2DB25FFJ15
Award Date
1/30/25
Potential Completion Date
2/21/25
Potential Value
$44K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,826.19, is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, with a period of performance running through November 20, 2024. The contract is not designated as a set-aside and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $94,112.92, is for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML medical supplies. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 23, 2022. This award is not associated with a set-aside program. AmerisourceBergen holds a...
This federal contract award, valued at $46,826.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of July 1, 2024. It is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distribution company, has been awarded this contract based on...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,835.28 firm fixed-price delivery order is for the supply of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor and there is no indication of set-aside...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty medication. The $46,826.19 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency responsible for supplying medical commodities to military healthcare providers. The contract has an ultimate completion date of August 26, 2024. AmerisourceBergen, through its Corporate...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product, with a ceiling value of $46,826.19. The contract has a firm fixed price pricing type and an ultimate completion date of October 16, 2024. This award is not associated with any set-aside program. Amerisourcebergen, a major supplier of...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product. The contract has a ceiling value of $93,652.38 and an ultimate completion date of July 30, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award, valued at $51,082.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product, with a completion date of July 15, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. The total ceiling value of the contract is $106,187.70, with a period of performance ending on February 18, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
The U.S. Defense Logistics Agency (DLA) awarded a $76,848.00 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of ULTOMIRIS 300 MG/3 ML VIAL 3ML medical supplies. This contract, with a performance period ending on April 21, 2023, is a firm fixed-price contract without any set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has a significant Indefinite Delivery Contract...